Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung Cancer
Status:
Completed
Trial end date:
2016-08-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look for an improvement in progression free survival with the
combination of bevacizumab, carboplatin and pemetrexed in patients with newly diagnosed
advanced/metastatic non small cell lung cancer. Overall survival and safety will also be
assessed.